Last 12 months
Inside the activity.
9 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2024 Filed Aug 6, 2024 21:54 UTC |
KAVANAGH SARAH BDirector
|
GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021756 · form4.xml · nonDerivative · entry 1 KAVANAGH SARAH B · CIK 0001681171 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,361 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 21:52 UTC |
ICAHN BRETTDirector
|
GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021755 · form4.xml · nonDerivative · entry 1 ICAHN BRETT · CIK 0001387184 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,809 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 21:50 UTC |
Hu GaoxiangDirector
|
GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021753 · form4.xml · nonDerivative · entry 1 Hu Gaoxiang · CIK 0001839091 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,809 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 21:49 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021752 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,325 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 23:05 UTC |
Hashad YehiaEVP of R&D and CMO
|
Tax withholdingCommon Shares, No Par Value | 2,841 | $15.53 | $44,120.73 |
DisclosureSEC source: 0001127602-24-021127 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,430 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 23:23 UTC |
Munsch FrederickSVP, Controller and CAO
|
Tax withholdingCommon Shares, No Par Value | 1,313 | $15.53 | $20,390.89 |
DisclosureSEC source: 0001127602-24-021130 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,813 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 23:22 UTC |
Bonnefoy LucPresident,Surgical
|
Tax withholdingCommon Shares, No Par Value | 2,144 | $15.53 | $33,296.32 |
DisclosureSEC source: 0001127602-24-021129 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,067 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 23:17 UTC |
Eldessouky SamEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 5,113 | $15.53 | $79,404.89 |
DisclosureSEC source: 0001127602-24-021128 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,667 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:36 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,506 | $14.52 | $21,867.12 |
DisclosureSEC source: 0001127602-24-019938 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,044 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:35 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,764 | $14.52 | $25,613.28 |
DisclosureSEC source: 0001127602-24-019936 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,670 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:01 UTC |
Bonnefoy LucPresident,Surgical
|
Tax withholdingCommon Shares, No Par Value | 958 | $15.09 | $14,456.22 |
DisclosureSEC source: 0001127602-24-018923 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,211 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| April 24, 2024 Filed Apr 26, 2024 20:10 UTC |
Stewart Andrew J.See remarks
|
Tax withholdingCommon Shares, No Par Value | 3,943 | $14.90 | $58,750.70 |
DisclosureSEC source: 0001127602-24-013450 · form4.xml · nonDerivative · entry 1 Stewart Andrew J. · CIK 0001974516 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,985 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| April 24, 2024 Filed Apr 26, 2024 20:08 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
Tax withholdingCommon Shares, No Par Value | 9,838 | $14.90 | $146,586.20 |
DisclosureSEC source: 0001127602-24-013447 · form4.xml · nonDerivative · entry 1 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,219 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 16:04 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 1,553 | $17.30 | $26,866.90 |
DisclosureSEC source: 0001127602-24-011811 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,952 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:09 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,481 | $17.30 | $25,621.30 |
DisclosureSEC source: 0001127602-24-011820 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,906 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:07 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,264 | $17.30 | $21,867.20 |
DisclosureSEC source: 0001127602-24-011816 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,538 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:09 UTC |
Ling KarenDirector
|
GrantCommon Shares, No Par Value | 2,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009005 · form4.xml · nonDerivative · entry 1 Ling Karen · CIK 0001597450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,642 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:57 UTC |
Hashad YehiaEVP of R&D and CMO
|
Tax withholdingCommon Shares, No Par Value | 2,143 | $16.47 | $35,295.21 |
DisclosureSEC source: 0001127602-24-008228 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,271 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:54 UTC |
Munsch FrederickSVP, Controller and CAO
|
Tax withholdingCommon Shares, No Par Value | 995 | $16.47 | $16,387.65 |
DisclosureSEC source: 0001127602-24-008221 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,126 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:52 UTC |
Bonnefoy LucPresident,Surgical
|
Tax withholdingCommon Shares, No Par Value | 1,098 | $16.47 | $18,084.06 |
DisclosureSEC source: 0001127602-24-008215 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,169 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:32 UTC |
Eldessouky SamEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 4,854 | $16.47 | $79,945.38 |
DisclosureSEC source: 0001127602-24-008141 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,780 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:43 UTC |
Hashad YehiaEVP of R&D and CMO
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 63,516 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001127602-24-007904 · form4.xml · derivative · entry 2 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,516 Underlying: Common Shares, No Par Value · 63,516 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:43 UTC |
Hashad YehiaEVP of R&D and CMO
|
GrantCommon Shares, No Par Value | 20,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007904 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,414 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:45 UTC |
Munsch FrederickSVP, Controller and CAO
|
GrantCommon Shares, No Par Value | 18,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007907 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,121 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:41 UTC |
Bonnefoy LucPresident,Surgical
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 50,813 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001127602-24-007903 · form4.xml · derivative · entry 2 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,813 Underlying: Common Shares, No Par Value · 50,813 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:41 UTC |
Bonnefoy LucPresident,Surgical
|
GrantCommon Shares, No Par Value | 16,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007903 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President,Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,267 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:35 UTC |
Stewart Andrew J.See remarks
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 50,813 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001127602-24-007900 · form4.xml · derivative · entry 2 Stewart Andrew J. · CIK 0001974516 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,813 Underlying: Common Shares, No Par Value · 50,813 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:35 UTC |
Stewart Andrew J.See remarks
|
GrantCommon Shares, No Par Value | 16,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007900 · form4.xml · nonDerivative · entry 1 Stewart Andrew J. · CIK 0001974516 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,928 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:28 UTC |
Eldessouky SamEVP and CFO
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 152,439 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001127602-24-007889 · form4.xml · derivative · entry 2 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,439 Underlying: Common Shares, No Par Value · 152,439 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:28 UTC |
Eldessouky SamEVP and CFO
|
GrantCommon Shares, No Par Value | 50,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007889 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,634 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:26 UTC |
SAUNDERS BRENT LDirector · CEO and Chair
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 569,105 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001127602-24-007883 · form4.xml · derivative · entry 2 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569,105 Underlying: Common Shares, No Par Value · 569,105 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:26 UTC |
SAUNDERS BRENT LDirector · CEO and Chair
|
GrantCommon Shares, No Par Value | 187,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007883 · form4.xml · nonDerivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 562,919 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:22 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
GrantNon-Qualified Stock Options (right to purchase) · Derivative | 101,626 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001127602-24-007872 · form4.xml · derivative · entry 2 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,626 Underlying: Common Shares, No Par Value · 101,626 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase common shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:22 UTC |
Bailey A Robert DEVP & Chief Legal Officer
|
GrantCommon Shares, No Par Value | 33,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007872 · form4.xml · nonDerivative · entry 1 Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,057 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 16:41 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 1,575 | $17.06 | $26,869.50 |
DisclosureSEC source: 0001127602-24-000483 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,399 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:44 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,502 | $17.06 | $25,624.12 |
DisclosureSEC source: 0001127602-24-000493 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,425 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:42 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,282 | $17.06 | $21,870.92 |
DisclosureSEC source: 0001127602-24-000487 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,274 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:39 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 1,465 | $17.06 | $24,992.90 |
DisclosureSEC source: 0001127602-24-000475 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,629 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 17:15 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 1,585 | $16.95 | $26,865.75 |
DisclosureSEC source: 0001127602-23-025311 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,824 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 21:18 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,511 | $16.95 | $25,611.45 |
DisclosureSEC source: 0001127602-23-025316 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,923 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 21:16 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,290 | $16.95 | $21,865.50 |
DisclosureSEC source: 0001127602-23-025314 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,992 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 21:14 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 1,474 | $16.95 | $24,984.30 |
DisclosureSEC source: 0001127602-23-025307 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,164 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:06 UTC |
Hashad YehiaEVP of R&D and CMO
|
Tax withholdingCommon Shares, No Par Value | 3,996 | $19.82 | $79,200.72 |
DisclosureSEC source: 0001127602-23-021415 · form4.xml · nonDerivative · entry 1 Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,441 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:07 UTC |
Munsch FrederickSVP, Controller and CAO
|
Tax withholdingCommon Shares, No Par Value | 1,313 | $19.82 | $26,023.66 |
DisclosureSEC source: 0001127602-23-021417 · form4.xml · nonDerivative · entry 1 Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,938 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:05 UTC |
Bonnefoy LucPresident, Surgical
|
Tax withholdingCommon Shares, No Par Value | 2,240 | $19.82 | $44,396.80 |
DisclosureSEC source: 0001127602-23-021414 · form4.xml · nonDerivative · entry 1 Bonnefoy Luc · CIK 0001980767 · President, Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,489 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:03 UTC |
Eldessouky SamEVP and CFO
|
Tax withholdingCommon Shares, No Par Value | 4,218 | $19.82 | $83,600.76 |
DisclosureSEC source: 0001127602-23-021411 · form4.xml · nonDerivative · entry 1 Eldessouky Sam · CIK 0001558676 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,299 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 16:05 UTC |
DE SCHUTTER RICHARD UDirector
|
GrantCommon Shares, No Par Value | 1,339 | $20.07 | $26,873.73 |
DisclosureSEC source: 0001127602-23-019996 · form4.xml · nonDerivative · entry 1 DE SCHUTTER RICHARD U · CIK 0001083205 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,239 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:12 UTC |
ROBERTSON RUSSEL CDirector
|
GrantCommon Shares, No Par Value | 1,276 | $20.07 | $25,609.32 |
DisclosureSEC source: 0001127602-23-020015 · form4.xml · nonDerivative · entry 1 ROBERTSON RUSSEL C · CIK 0001677301 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,412 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:11 UTC |
Paulson JohnDirector
|
GrantCommon Shares, No Par Value | 1,089 | $20.07 | $21,856.23 |
DisclosureSEC source: 0001127602-23-020012 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,702 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:03 UTC |
Bernier Nathalie D.Director
|
GrantCommon Shares, No Par Value | 1,245 | $20.07 | $24,987.15 |
DisclosureSEC source: 0001127602-23-019991 · form4.xml · nonDerivative · entry 1 Bernier Nathalie D. · CIK 0001903043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,690 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.